Top White House scientist resigns after review finds he demeaned staff
By Tyler Pager,
The Washington Post
| 02. 07. 2022
"Keynote speaker Eric Lander 1" by afagen
is licensed under CC BY-SA 2.0
Eric Lander, President Biden’s top science adviser, resigned Monday night after he acknowledged mistreating his subordinates and apologized for demeaning them, a pattern of behavior that put him at odds with one of Biden’s earliest promises — to run an administration marked by respect and professionalism.
An internal review by the White House found credible evidence that Lander, director of the Office of Science and Technology Policy, bullied staff in violation of the White House’s “safe and respectful workplace policy,” which was intended in part to draw a contrast with the Trump administration.
Lander’s resignation came after the White House struggled throughout the day to explain why he had not quit or been fired, and how that squared with a pledge Biden made on his first day in office. On that day, he told staffers at swearing-in ceremony, “If you are ever working with me and I hear you treat another colleague with disrespect, talk down to someone, I promise you I will fire you on...
Related Articles
By Ian Sample, The Guardian | 07.04.2024
Biological models of human embryos that can develop heartbeats, spinal cords and other distinctive features will be governed by a code of practice in Britain to ensure that researchers work on them responsibly.
Made from stem cells, they mimic, to...
By Kevin Davies, Genetic Engineering & Biotechnology News | 06.27.2024
Physician-scientist Matthew Porteus, MD, PhD, has been a mainstay in the genome editing field for more than two decades. He trained at Stanford University Medical School before completing his residency and hematology/oncology fellowship at Boston Children’s Hospital/Dana Farber Cancer Institute...
By Peter Aldhous, Scientific American | 07.02.2024
In June a notice posted on the website of the journal Nature set a new scientific record. It withdrew what is now the most highly cited research paper ever to be retracted.
The study, published in 2002 by Catherine Verfaillie...
By Robert F. Service, Science | 07.04.2024
Image by Ed Uthman from Flickr
Last year, the U.S. Food and Drug Administration (FDA) approved two gene therapy procedures that can treat and, in some cases essentially cure sickle cell disease, a genetic blood disorder that causes pain and...